Credit Suisse’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Credit Suisse’s Portfolio BITI Stock Details BITI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-98,063	Closed	-$2.59M	–	4454
2016 Q1	$2.59M	Buy	+98,063	New	+$2.29M	﹤0.01%	2010

Credit Suisse's BITI Position: Q2 2016 in Review

Credit Suisse sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 98,063 shares — an estimated $2.59M sold.

Credit Suisse first reported a position in BITI in Q1 2016 and held it in 1 quarter. The position peaked at $2.59M in Q1 2016. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

Credit Suisse reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
Credit Suisse sold 98,063 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $2.59M.
Credit Suisse first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q1 2016 and held it in 1 quarter.
Credit Suisse's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $2.59M in Q1 2016.
0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.